[go: up one dir, main page]

US20050085642A1 - Novel bipyridine derivatives - Google Patents

Novel bipyridine derivatives Download PDF

Info

Publication number
US20050085642A1
US20050085642A1 US10/916,530 US91653004A US2005085642A1 US 20050085642 A1 US20050085642 A1 US 20050085642A1 US 91653004 A US91653004 A US 91653004A US 2005085642 A1 US2005085642 A1 US 2005085642A1
Authority
US
United States
Prior art keywords
group
unsubstituted
substituted
monosubstituted
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US10/916,530
Other versions
US7301029B2 (en
Inventor
Hirokazu Kuwabara
Takayuki Sonoda
Hiromitsu Saitoh
Hidehiro Arai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujifilm Finechemicals Co Ltd
Original Assignee
Fujifilm Finechemicals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujifilm Finechemicals Co Ltd filed Critical Fujifilm Finechemicals Co Ltd
Assigned to SANKIO CHEMICAL CO., LTD. reassignment SANKIO CHEMICAL CO., LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ARAI, HIDEHIRO, KUWABARA, HIROKAZU, SAITOH, HIROMITSU, SONODA, TAKAYUKI
Publication of US20050085642A1 publication Critical patent/US20050085642A1/en
Assigned to FUJIFILM FINECHEMICALS CO., LTD. reassignment FUJIFILM FINECHEMICALS CO., LTD. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: SANKIO CHEMICAL CO., LTD.
Application granted granted Critical
Publication of US7301029B2 publication Critical patent/US7301029B2/en
Adjusted expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/48—Aldehydo radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals

Definitions

  • the present invention relates to a bipyridine derivative functioning as an important intermediate in the fields of for example pharmaceutical products, agricultural chemicals, catalyst ligands, combinatorial chemistry, organic electroluminescence devices, electron charge transfer substances, electrophotograpic photosensitive substances and dyes.
  • bipyridine derivatives mainly including 2,4′-bipyridine
  • the derivatives draw attention as very attractive compounds.
  • the derivatives are used as ⁇ 1A-selective antagonists (Canadian Journal of Chemistry, 2002, Vol.80, No. 6, pp. 646-652).
  • organoelectroluminescence devices for example, there are organoelectroluminescent materials using highly luminescent organic iridium complexes and an example of the use thereof for organoelectroluminescence devices (Official gazette of JP-A-2003-147345).
  • the inventors made investigations so as to achieve the object.
  • the inventors made a success in obtaining a novel bipyridine derivative useful as an important intermediate in the fields of for example pharmaceutical products, agricultural chemicals, catalyst ligands, combinatorial chemistry, electrophotographic photosensitive substances and dyes.
  • the invention has been achieved.
  • the invention includes the following aspects.
  • R1 represents an alkyl group with 2 to 20 carbon atoms having a substituent, an alkoxy group with 1 to 20 carbon atoms, which may have a substituent, an alkylthio group with 1 to 20 carbon atoms, which may have a substituent, unsubstituted or monosubstituted amino group, nitro group, formyl group, cyano group, unsubstituted or monosubstituted carbamoyl group or substituted carbonylamino group.
  • a pyridine derivative useful as an intermediate for pharmaceutical products, agricultural chemicals, electrophotographic photosensitive substances, dyes and the like can be provided.
  • R1 in the formula (I) represents an alkyl group with 2 to 20 carbon atoms having a substituent, substituted or unsubstituted aminomethyl group, trifluoromethyl group, substituted or unsubstituted thiomethyl group, substituted or unsubstituted alkenyl group, substituted or unsubstituted alkoxy group, substituted or unsubstituted aryloxy group, substituted carbonyl group, substituted sulfonyl group, unsubstituted or monosubstituted carbamoyl group, unsubstituted or monosubstituted sulfamoyl group, substituted or unsubstituted thiol group, unsubstituted or monosubstituted amino group, substituted carbonylamino group, substituted or unsubstituted ureido group, nitro group, cyano group, formyl group or an equivalent thereof, iodine
  • the alkyl group with 2 to 20 carbon atoms having a substituent as represented by R1 in the general formula (I) is an alkyl group with 2 to 20 carbon atoms, where at least one substituent is bound.
  • the substituent which the alkyl group with 2 to 20 carbon atoms may have includes for example amino group, halogen atoms, thiol group, aryl group, hetero-ring residues, and alkoxy group. These groups may additionally have substituents.
  • the aminoalkyl group as the substituted alkyl group in R1 includes for example aminoethyl, aminododecyl, aminooctadecyl, N-methylaminoethyl, N-methylaminohexyl, N-methylaminohexadecyl, N,N-diethylaminoethyl, N,N-diethylaminooctyl, N,N-diethylaminohexadecyl, N-phenylaminoethyl, N-phenylaminotetradecyl, N,N-diphenylaminoethyl and N,N-diphenylaminononyl.
  • the halogenated alkyl group as the substituted alkyl group in R1 is preferably fluoroalkyl group and more preferably perfluoroalkyl group, and specifically includes pentafluoroethyl, tridecafluorohexyl, and tritriacontafluorohexadecyl.
  • the arylalkyl group as the substituted alkyl group in R1 includes for example phenylethyl, phenyldecyl and naphthylpropyl.
  • Thioalkyl group as the substituted alkyl group in R1 includes for example methylthioethyl, methylthiopropyl, ethylthiobutyl, methylthiopentyl, propylthiohexyl, methythioheptyl, phenylthiooctyl, methylthiononyl, ethylthiodecyl, propylthiododecyl and phenylthiohexadecyl.
  • the hetero ring which the substituted alkyl group in R1 may have includes for example thiophene, furan, pyran, pyridine, pyrrole, pyrazine, azepine, azosine, azonine, azesine, oxazole, thiazole, pyrimidine, pyridazine, triazine, triazole, tetrazole, imidazole, pyrazole, morpholine, thiomorpholine, piperidine, piperazine, quinoline, isoquinoline, indole, isoindole, quinoxaline, phthalazine, quinolizine, quinazoline, quinoxaline, naphthyridine, chromene, benzofuran, and benzothiophene.
  • the hetero ring is a 5-membered or 6-membered hetero ring.
  • the alkoxyalkyl group as the substituted alkyl group in R1 includes for example methoxyethyl, ethoxyethyl, methoxypropyl, methoxyhexyl, ethoxyoctyl, butoxyhexadecyl and methoxyoctadecyl.
  • the substituted aminomethyl group in R1 includes for example N-methylaminomethyl, N-ethylaminomethyl, N-hexylaminomethyl, N-phenylaminomethyl, N,N-dimethylaminomethyl, N,N-diethylaminomethyl, N,N-dioctylaminomethyl, and N, N-diphenylaminomethyl.
  • the substituted thiomethyl group as R1 includes for example methylthiomethyl, butylthiomethyl, dodecylthiomethyl, and phenylthiomethyl.
  • the alkenyl group as R1 includes for example linear, branched or cyclic alkenyl groups such as vinyl, allyl, propenyl, butenyl, pentenyl, hexenyl, heptenyl, octenyl, nonenyl, decenyl, undecenyl, dodecenyl, tridecenyl, tetradecenyl, pentadecenyl, hexadecenyl, heptadecenyl, octadecenyl, nonadecenyl, icosenyl, hexadienyl, and dodecatrienyl.
  • the alkenyl group as R1 preferably has 2 to 20 carbon atoms.
  • the alkoxy group as R1 includes for example methoxy, ethoxy, propoxy, butoxy, pentyloxy, hexyloxy, heptyloxy, octyloxy, nonyloxy, decyloxy, dodecyloxy, and octadecyloxy.
  • the alkoxy group as R1 preferably has one to 20 carbon atoms.
  • the aryloxy group in R1 includes for example phenoxy, and naphthyloxy.
  • the substituted carbonyl group in R1 includes for example acetyl, propanoyl, butanoyl, pentanoyl, hexanoyl, heptanoyl, benzoyl and naphthoyl.
  • the substituted sulfonyl group as R1 includes for example methylsulfonyl, ethylsulfonyl, propylsulfonyl, butylsulfonyl, pentylsulfonyl, hexylsulfonyl, heptylsulfonyl, octylsulfonyl, phenylsulfonyl and naphthylsulfonyl.
  • the monosubstituted carbamoyl group in R1 includes monosubstituted carbamoyl groups substituted with one group, for example N-methylcarbamoyl, N-(tert-butyl)carbamoyl, N-dodecylcarbamoyl and N-phenylcarbamoyl.
  • the monosubstituted sulfamoyl group in R1 includes monosubstituted sulfamoyl groups substituted with one group, for example N-ethylsulfamoyl, N-(iso-hexyl)sulfamoyl, N-hexadecylsulfamoyl and N-phenylsulfamoyl.
  • the substituted thiol group in R1 includes for example methylthio, ethylthio, propylthio, butylthio, pentylthio, hexylthio, heptylthio, octylthio, nonylthio, decylthio, dodecylthio, hexadecylthio, phenylthio, naphthylthio, 2-pyrimidylthio, and 4-pyridylthio.
  • the monosubstituted amino group in R1 includes monosubstituted amino group groups substituted with one group, for example N-methylamino, N-ethylamino, N-octylamino, N-hexadecylamino, and N-phenylamino.
  • the substituted carbonylamino group in R1 includes for example acetylamino, ethylcarbonylamino, tert-butylcarbonylamino, n-octylcarbonylamino, n-hexadecylcarbonylamino, benzoylamino, naphthoylamino, methoxycarbonylamino, ethoxycarbonylamino, n-octyloxycarbonylamino and n-hexadecyloxycarbonylamino.
  • the substituted ureido group in R1 includes for example N-methylureido, N-(iso-butyl)ureido, N-hexylureido, N-octadecylureido, and N-phenylureido.
  • the equivalent of formyl group in R1 includes for example di-alkoxymethyl group such as dimethoxymethyl and diethoxymethyl; trialkoxymethyl group such as trimethoxymethyl and triethoxyethyl; dialkylthiomethyl group such as dimethylthiomethyl and diethylthiomethyl; trialkylthiomethyl group such as trimethylthiomethyl and triethylthiomethyl; 1,3-dioxolanyl group; and 1,3-dithiolanyl group.
  • di-alkoxymethyl group such as dimethoxymethyl and diethoxymethyl
  • trialkoxymethyl group such as trimethoxymethyl and triethoxyethyl
  • dialkylthiomethyl group such as dimethylthiomethyl and diethylthiomethyl
  • trialkylthiomethyl group such as trimethylthiomethyl and triethylthiomethyl
  • 1,3-dioxolanyl group 1,3-dithiolanyl group.
  • substituents may additionally have any substituents with no specific limitation.
  • the additional substituents include for example but are not limited to alkyl, alkenyl, phenyl, alkoxy, phenoxy, benzyloxy, amino, alkylthio, phenylthio and halogen atom.
  • R1 is preferably an alkyl group with 2 to 20 carbon atoms and with substituents, an alkoxy group with one to 20 carbon atoms, which may or may not have a substituent, an alkylthio group with one to 20 carbon atoms, which may or may not have a substituent, unsubstituted or monosubstituted amino group, nitro group, formyl group, cyano group, unsubstituted or monosubstituted carbamoyl group or substituted carbonylamino group. More preferably, R1 is unsubstituted amino group, nitro group, formyl group, cyano group, unsubstituted carbamoyl group or carbonylamino group substituted with a lower alkyl group.
  • the compound represented by the general formula (I) in accordance with the invention can be converted to a salt by known methods.
  • the salt includes for example alkali metal salts, alkali earth metal salts, ammonium salts, ammine salts and acid addition salts.
  • Appropriate examples of them include salts with alkali metals such as potassium and sodium; salts with alkali earth metals such as calcium and magnesium; salts with ammonium such as tetramethylammonium; salts with organic amines such as triethylamine, methylamine, dimethylamine, cyclopentylamine, benzylamine, phenetylamine, piperidine, monoethanolamine, diethanolamine, tris(hydroxymethyl)aminomethane, lysine, arginine, and N-methyl-D-glucamine.
  • alkali metals such as potassium and sodium
  • salts with alkali earth metals such as calcium and magnesium
  • salts with ammonium such as tetramethylammonium
  • salts with organic amines such as triethylamine, methylamine, dimethylamine, cyclopentylamine, benzylamine, phenetylamine, piperidine, monoethanolamine, diethanolamine, tris(
  • Appropriate acid addition salts include for example inorganic acid salts such as hydrochloride salt, hydrobromide salt, hydroiodide salt, sulfate salt, phosphate salt, and nitrate salt; organic acid salts such as acetate salt, lactate salt, tartrate salt, benzoate salt, citrate salt, methanesulfonate salt, ethanesulfonate salt, benzenesulfonate salt, toluenesulfonate salt, isethionate salt, glucuronate salt, and gluconate salt.
  • inorganic acid salts such as hydrochloride salt, hydrobromide salt, hydroiodide salt, sulfate salt, phosphate salt, and nitrate salt
  • organic acid salts such as acetate salt, lactate salt, tartrate salt, benzoate salt, citrate salt, methanesulfonate salt, ethanesulfonate salt, benzenesul
  • the method for producing the compound represented by the general formula (I) is now described below.
  • the bipyridine derivative of the invention can be produced synthetically by known methods, for example methods described in JP-A-2000-355580, JP-A-2001-261646, JP-A-2001-261647, JP-A-2001-261653 and the like.
  • 4-acetylpyridines and 3-amino-2-propenals react together; then, the resulting reaction product reacts with ammonia or an ammonium salt to produce the compound.
  • One example of the reaction schemes is shown. However, the invention is never limited to the example.
  • R1 has the same meanings as described above.
  • R2 and R3 independently represent an appropriate substituent.
  • 3-Amino-2-propenals represented by the general formula (III) or (IV) (abbreviated as 3-amino-2-propenals hereinafter) for use in accordance with the invention can readily be available as commercial products or can readily be synthetically prepared in a simple manner by a method described in for example J. AM. Chem. Soc., 103, 3030 (1981); J. Chem. Soc. PERKINTRANS. I, 333 (1988); Collect. Czech. Chem. Commun., 61,1637 (1996); and Collect. Czech. Chem. Commun., 49, 2602 (1984).
  • 4-acetylpyridines represented by the general formula (II) as a raw material can readily be available as commercial products.
  • Acyl group can be introduced in pyridine compounds by Friedel-Crafts reaction (J. Org. Chem., 38, 1445 (1973); J. Am. Chem. Soc., 79, 1445 (1957); J. Am. Chem. Soc., 84, 813 (1962)).
  • a base is preferably allowed to exist during the condensation reaction between 4-acetylpyridines and 3-amino-2-propenals.
  • any base may be usable.
  • metal alkoxides such as potassium t-butoxide, sodium t-butoxide, and sodium ethoxide
  • inorganic bases such as sodium hydride, metal sodium, sodium hydroxide and potassium hydroxide
  • organic bases such as triethylamine, 1,8-diazabicyclo[5.4.0]undec-7-ene and diisopropylamine are used.
  • the base is potassium t-butoxide, sodium methoxide and sodium hydride. More preferably, the base is potassium t-butoxide. Additionally, two or more bases may be mixed and used. In case of using bases in mixture, the mix ratio may be appropriately determined.
  • the amount of the base to be used is within a range of 0.5- to 5-fold moles, preferably 0.5- to 1.5-fold moles, more preferably 0.8- to 1.2-fold moles to the amount of 3-amino-2-propenals.
  • the reaction is conducted at a temperature of ⁇ 78 to 200° C., preferably within a range of ⁇ 30 to 100° C., more preferably within a range of ⁇ 10 to 40° C. Generally, these reactions are on completion within 24 hours. In many cases, the elimination of the raw materials can be verified in 10 minutes to 12 hours.
  • Ammonium chloride, ammonium acetate and ammonium formate are preferable, and ammonium acetate is more preferable.
  • the reaction is carried out satisfactorily within a range of 1- to 30-fold moles, preferably 1- to 15-fold moles, more preferably 3- to 6-fold moles per one mole of 4-acetylpyridines.
  • two or more ammonia types in different forms can be mixed together for use. The mix ratio for use in mixture may appropriately be determined.
  • the temperature of the cyclization reaction is within a range of ⁇ 20 to 200° C., preferably within a range of 50 to 120° C., more preferably within a range of 70 to 100° C. Generally, these reactions are on completion within 24 hours. In many cases, the elimination of the raw materials can be confirmed in 10 minutes to 12 hours.
  • any particular catalyst is needed.
  • the reaction is completed in a shorter period of time, advantageously, when an acid catalyst is used.
  • the acid catalyst any acid catalysts may be used.
  • inorganic acids such as sulfuric acid and hydrochloric acid, organic acids such as p-toluenesulfonic acid, formic acid, acetic acid, and propionic acid, and ion exchange resins of strong acidity, such as Amberlite and Amberlist can be used.
  • Preferable are formic acid, acetic acid and propionic acid capable of retaining the inside of the reaction system at weak acidity. More preferable is acetic acid.
  • any polar solvents or non-polar solvents may be used, including for example water; aromatic solvents such asbenzene, toluene, xylene, chlorobenzene, and dichlorobenzene; polar solvents such as pyridine, acetonitrile, N,N-dimethylformamide, N,N-dimethylacetamide, N-methylpyrrolidone, and dimethylsulfoxide; ester solvents such as methyl acetate, ethyl acetate and butyl acetate; alcoholic solvents such as methanol, ethanol, isopropyl alcohol, butanol, and t-butanol; ether solvents such as diethyl ether, diisopropyl ether, dibutyl ether, methyl t-butyl ether, and tetrahydrofuran.
  • aromatic solvents such asbenzene, toluene, xylene, chlorobenzene, and dichlorobenz
  • the reaction solvent is used within a range of 0.1- to 50-fold by weight, preferably 0.5- to 30-fold by weight, more preferably 1- to 10-fold by weight to 4-acetylpyridines.
  • the method for purifying the bipyridine derivative as the object substance after completion of the reaction includes extraction using water and an organic solvent such as ethyl acetate or toluene which can be partitioned from water, recrystallization using alcohol, hexane, toluene and the like, column purification using silica gel or alumina or the like as an immobilization bed, distillation and the like. These methods may be used singly or in combination of two or more thereof, for purification, to obtain the object substance at high purity.
  • 3-(Dimethylamino)-2-nitro-2-propenal (60.5 g) was dissolved in tetrahydrofuran (500 ml). To the resulting solution were added 4-acetylpyridine (48.5 g) and potassium t-butoxide (121.14 g), for agitation at 30° C. for 30 minutes. After ammonium acetate (185 g) and acetic acid (140 ml) were added, reaction was progressed at an inner temperature of 95° C. for 4 hours while tetrahydrofuran was distilled off. To the reaction solution was added aqueous 25% NaOH solution (400 ml), for crystallization. The resulting crystal was dried to obtain the object compound in pale dark brown crystal (58 g; yield of 72%).
  • Table 1 shows the physico-chemical values of the object substances obtained in Examples 1 through 6. TABLE 1 Examples Melting point (° C.) MS [M + H+] 1 203-204 201 2 218-220 181 3 114-115 184 4 220-229 199 5 238-240 171 6 208-209 213
  • the pyridine derivatives obtained in accordance with the invention are useful as intermediates for pharmaceutical products, agricultural chemicals, electrophotographic photosensitive materials, dyes and the like.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)

Abstract

The invention provides a bipyridine derivative useful as an intermediate for pharmaceutical products, agricultural chemicals, electrophotographic photosensitive materials, dyes and the like, which is a bipyridine derivative represented by the general formula (I) and a salt thereof:
Figure US20050085642A1-20050421-C00001
 wherein R1 represents an alkyl group with 2 to 20 carbon atoms having a substituent, substituted or unsubstituted aminomethyl group, trifluoromethyl group, substituted or unsubstituted thiomethyl group, substituted or unsubstituted alkenyl group, substituted or unsubstituted alkoxy group, substituted or unsubstituted aryloxy group, substituted carbonyl group, substituted sulfonyl group, unsubstituted or monosubstituted carbamoyl group, unsubstituted or monosubstituted sulfamoyl group, substituted or unsubstituted thiol group, unsubstituted or monosubstituted amino group, substituted carbonylamino group, substituted or unsubstituted ureido group, nitro group, cyano group, formyl group or an equivalent thereof, iodine atom or fluorine atom.

Description

    BACKGROUND OF THE INVENTION
  • 1. Field of the Invention
  • The present invention relates to a bipyridine derivative functioning as an important intermediate in the fields of for example pharmaceutical products, agricultural chemicals, catalyst ligands, combinatorial chemistry, organic electroluminescence devices, electron charge transfer substances, electrophotograpic photosensitive substances and dyes.
  • 2. Description of the Related Art
  • Use of bipyridine derivatives mainly including 2,4′-bipyridine is developed for a wide variety of fields. The derivatives draw attention as very attractive compounds. In the fields of recent pharmaceutical and agricultural chemicals, for example, the derivatives are used as α1A-selective antagonists (Canadian Journal of Chemistry, 2002, Vol.80, No. 6, pp. 646-652).
  • In the field of ligands, additionally, numerous reports have been issued including a report about the use thereof as a ligand for ruthenium metal (Canadian Journal of Chemistry, 2002, Vol. 80, No. 6, pp. 646-652), as ligands for copper and cadmium (Journal of Organometallic Chemistry, 2002, Vol. 655, pp. 31-38) and as a ligand for manganese (II), cobalt (II), nickel (II) or copper (II) (Polish Journal of Chemistry, 2002, Vol. 76, No. 7, pp. 1047-1052).
  • As organoelectroluminescence devices, for example, there are organoelectroluminescent materials using highly luminescent organic iridium complexes and an example of the use thereof for organoelectroluminescence devices (Official gazette of JP-A-2003-147345).
  • In the photosensitive field, the use thereof for the purpose of providing a silver halide photosensitive material with high sensitivity, improved storability of fresh samples and less contamination of dyes is reported (Official gazette of JP-A-2001-152044).
  • As dye enhancers, a report tells about a photoelectrochemical battery of dye enhancement type and with less electricity generation loss as well as the usefulness of a bipyridine-carboxylic acid-ruthenium (II) complex hydrate as a dye enhancer for photoelectrochemical battery of dye enhancement type and with smaller inner resistance (Official gazette of JP-A-2003-163037).
  • In a wide variety of fields, additionally, as many as 200 patents and references report the assessment of their usefulness (Journal of Thermal Analysis and Calorimetry, 2000, Vol. 60, No. 1, pp. 145-150).
    • SUMMARY OF THE INVENTION
  • It is an object of the invention to provide a bipyridine derivative functioning as an important intermediate in the fields of for example pharmaceutical products, agricultural chemicals, catalyst ligands, combinatorial chemistry, organoelectroluminescence devices, electron charge transfer substances, electrophotographic photosensitive substances and dyes.
  • The inventors made investigations so as to achieve the object. The inventors made a success in obtaining a novel bipyridine derivative useful as an important intermediate in the fields of for example pharmaceutical products, agricultural chemicals, catalyst ligands, combinatorial chemistry, electrophotographic photosensitive substances and dyes. Thus, the invention has been achieved.
  • The invention includes the following aspects.
  • 1. A bipyridine derivative represented by the general formula (I) and a salt thereof:
    Figure US20050085642A1-20050421-C00002
    wherein R1 represents an alkyl group with 2 to 20 carbon atoms having a substituent, substituted or unsubstituted aminomethyl group, trifluoromethyl group, substituted or unsubstituted thiomethyl group, substituted or unsubstituted alkenyl group, substituted or unsubstituted alkoxy group, substituted or unsubstituted aryloxy group, substituted carbonyl group, substituted sulfonyl group, unsubstituted or monosubstituted carbamoyl group, unsubstituted or monosubstituted sulfamoyl group, substituted or unsubstituted thiol group, unsubstituted or monosubstituted amino group, substituted carbonylamino group, substituted or unsubstituted ureido group, nitro group, cyano group, formyl group or an equivalent thereof, iodine atom or fluorine atom).
  • 2. The bipyridine derivative and a salt thereof described above in 1, wherein R1 represents an alkyl group with 2 to 20 carbon atoms having a substituent, an alkoxy group with 1 to 20 carbon atoms, which may have a substituent, an alkylthio group with 1 to 20 carbon atoms, which may have a substituent, unsubstituted or monosubstituted amino group, nitro group, formyl group, cyano group, unsubstituted or monosubstituted carbamoyl group or substituted carbonylamino group.
  • 3. The bipyridine derivative and a salt thereof described above in 1, wherein R1 represents unsubstituted amino group, nitro group, formyl group, cyano group, unsubstituted carbamoyl group or carbonylamino group substituted with a lower alkyl group.
  • In accordance with the invention, a pyridine derivative useful as an intermediate for pharmaceutical products, agricultural chemicals, electrophotographic photosensitive substances, dyes and the like can be provided.
    • DETAILED DESCRIPTION OF THE INVENTION
  • The invention is now described in detail hereinbelow.
  • In accordance with the invention, R1 in the formula (I) represents an alkyl group with 2 to 20 carbon atoms having a substituent, substituted or unsubstituted aminomethyl group, trifluoromethyl group, substituted or unsubstituted thiomethyl group, substituted or unsubstituted alkenyl group, substituted or unsubstituted alkoxy group, substituted or unsubstituted aryloxy group, substituted carbonyl group, substituted sulfonyl group, unsubstituted or monosubstituted carbamoyl group, unsubstituted or monosubstituted sulfamoyl group, substituted or unsubstituted thiol group, unsubstituted or monosubstituted amino group, substituted carbonylamino group, substituted or unsubstituted ureido group, nitro group, cyano group, formyl group or an equivalent thereof, iodine atom or fluorine atom.
  • The alkyl group with 2 to 20 carbon atoms having a substituent as represented by R1 in the general formula (I) is an alkyl group with 2 to 20 carbon atoms, where at least one substituent is bound.
  • The substituent which the alkyl group with 2 to 20 carbon atoms may have includes for example amino group, halogen atoms, thiol group, aryl group, hetero-ring residues, and alkoxy group. These groups may additionally have substituents.
  • The aminoalkyl group as the substituted alkyl group in R1 includes for example aminoethyl, aminododecyl, aminooctadecyl, N-methylaminoethyl, N-methylaminohexyl, N-methylaminohexadecyl, N,N-diethylaminoethyl, N,N-diethylaminooctyl, N,N-diethylaminohexadecyl, N-phenylaminoethyl, N-phenylaminotetradecyl, N,N-diphenylaminoethyl and N,N-diphenylaminononyl.
  • The halogenated alkyl group as the substituted alkyl group in R1 is preferably fluoroalkyl group and more preferably perfluoroalkyl group, and specifically includes pentafluoroethyl, tridecafluorohexyl, and tritriacontafluorohexadecyl.
  • The arylalkyl group as the substituted alkyl group in R1 includes for example phenylethyl, phenyldecyl and naphthylpropyl.
  • Thioalkyl group as the substituted alkyl group in R1 includes for example methylthioethyl, methylthiopropyl, ethylthiobutyl, methylthiopentyl, propylthiohexyl, methythioheptyl, phenylthiooctyl, methylthiononyl, ethylthiodecyl, propylthiododecyl and phenylthiohexadecyl.
  • The hetero ring which the substituted alkyl group in R1 may have includes for example thiophene, furan, pyran, pyridine, pyrrole, pyrazine, azepine, azosine, azonine, azesine, oxazole, thiazole, pyrimidine, pyridazine, triazine, triazole, tetrazole, imidazole, pyrazole, morpholine, thiomorpholine, piperidine, piperazine, quinoline, isoquinoline, indole, isoindole, quinoxaline, phthalazine, quinolizine, quinazoline, quinoxaline, naphthyridine, chromene, benzofuran, and benzothiophene. Preferably, the hetero ring is a 5-membered or 6-membered hetero ring.
  • The alkoxyalkyl group as the substituted alkyl group in R1 includes for example methoxyethyl, ethoxyethyl, methoxypropyl, methoxyhexyl, ethoxyoctyl, butoxyhexadecyl and methoxyoctadecyl.
  • The substituted aminomethyl group in R1 includes for example N-methylaminomethyl, N-ethylaminomethyl, N-hexylaminomethyl, N-phenylaminomethyl, N,N-dimethylaminomethyl, N,N-diethylaminomethyl, N,N-dioctylaminomethyl, and N, N-diphenylaminomethyl.
  • The substituted thiomethyl group as R1 includes for example methylthiomethyl, butylthiomethyl, dodecylthiomethyl, and phenylthiomethyl.
  • The alkenyl group as R1 includes for example linear, branched or cyclic alkenyl groups such as vinyl, allyl, propenyl, butenyl, pentenyl, hexenyl, heptenyl, octenyl, nonenyl, decenyl, undecenyl, dodecenyl, tridecenyl, tetradecenyl, pentadecenyl, hexadecenyl, heptadecenyl, octadecenyl, nonadecenyl, icosenyl, hexadienyl, and dodecatrienyl. The alkenyl group as R1 preferably has 2 to 20 carbon atoms.
  • The alkoxy group as R1 includes for example methoxy, ethoxy, propoxy, butoxy, pentyloxy, hexyloxy, heptyloxy, octyloxy, nonyloxy, decyloxy, dodecyloxy, and octadecyloxy. The alkoxy group as R1 preferably has one to 20 carbon atoms.
  • The aryloxy group in R1 includes for example phenoxy, and naphthyloxy.
  • The substituted carbonyl group in R1 includes for example acetyl, propanoyl, butanoyl, pentanoyl, hexanoyl, heptanoyl, benzoyl and naphthoyl.
  • The substituted sulfonyl group as R1 includes for example methylsulfonyl, ethylsulfonyl, propylsulfonyl, butylsulfonyl, pentylsulfonyl, hexylsulfonyl, heptylsulfonyl, octylsulfonyl, phenylsulfonyl and naphthylsulfonyl.
  • The monosubstituted carbamoyl group in R1 includes monosubstituted carbamoyl groups substituted with one group, for example N-methylcarbamoyl, N-(tert-butyl)carbamoyl, N-dodecylcarbamoyl and N-phenylcarbamoyl.
  • The monosubstituted sulfamoyl group in R1 includes monosubstituted sulfamoyl groups substituted with one group, for example N-ethylsulfamoyl, N-(iso-hexyl)sulfamoyl, N-hexadecylsulfamoyl and N-phenylsulfamoyl.
  • The substituted thiol group in R1 includes for example methylthio, ethylthio, propylthio, butylthio, pentylthio, hexylthio, heptylthio, octylthio, nonylthio, decylthio, dodecylthio, hexadecylthio, phenylthio, naphthylthio, 2-pyrimidylthio, and 4-pyridylthio.
  • The monosubstituted amino group in R1 includes monosubstituted amino group groups substituted with one group, for example N-methylamino, N-ethylamino, N-octylamino, N-hexadecylamino, and N-phenylamino.
  • The substituted carbonylamino group in R1 includes for example acetylamino, ethylcarbonylamino, tert-butylcarbonylamino, n-octylcarbonylamino, n-hexadecylcarbonylamino, benzoylamino, naphthoylamino, methoxycarbonylamino, ethoxycarbonylamino, n-octyloxycarbonylamino and n-hexadecyloxycarbonylamino.
  • The substituted ureido group in R1 includes for example N-methylureido, N-(iso-butyl)ureido, N-hexylureido, N-octadecylureido, and N-phenylureido.
  • The equivalent of formyl group in R1 includes for example di-alkoxymethyl group such as dimethoxymethyl and diethoxymethyl; trialkoxymethyl group such as trimethoxymethyl and triethoxyethyl; dialkylthiomethyl group such as dimethylthiomethyl and diethylthiomethyl; trialkylthiomethyl group such as trimethylthiomethyl and triethylthiomethyl; 1,3-dioxolanyl group; and 1,3-dithiolanyl group.
  • These substituents may additionally have any substituents with no specific limitation. The additional substituents include for example but are not limited to alkyl, alkenyl, phenyl, alkoxy, phenoxy, benzyloxy, amino, alkylthio, phenylthio and halogen atom.
  • R1 is preferably an alkyl group with 2 to 20 carbon atoms and with substituents, an alkoxy group with one to 20 carbon atoms, which may or may not have a substituent, an alkylthio group with one to 20 carbon atoms, which may or may not have a substituent, unsubstituted or monosubstituted amino group, nitro group, formyl group, cyano group, unsubstituted or monosubstituted carbamoyl group or substituted carbonylamino group. More preferably, R1 is unsubstituted amino group, nitro group, formyl group, cyano group, unsubstituted carbamoyl group or carbonylamino group substituted with a lower alkyl group.
  • The compound represented by the general formula (I) in accordance with the invention can be converted to a salt by known methods.
  • Herein, the salt includes for example alkali metal salts, alkali earth metal salts, ammonium salts, ammine salts and acid addition salts.
  • Appropriate examples of them include salts with alkali metals such as potassium and sodium; salts with alkali earth metals such as calcium and magnesium; salts with ammonium such as tetramethylammonium; salts with organic amines such as triethylamine, methylamine, dimethylamine, cyclopentylamine, benzylamine, phenetylamine, piperidine, monoethanolamine, diethanolamine, tris(hydroxymethyl)aminomethane, lysine, arginine, and N-methyl-D-glucamine.
  • Appropriate acid addition salts include for example inorganic acid salts such as hydrochloride salt, hydrobromide salt, hydroiodide salt, sulfate salt, phosphate salt, and nitrate salt; organic acid salts such as acetate salt, lactate salt, tartrate salt, benzoate salt, citrate salt, methanesulfonate salt, ethanesulfonate salt, benzenesulfonate salt, toluenesulfonate salt, isethionate salt, glucuronate salt, and gluconate salt.
  • Specific examples of the compound represented by the general formula (I) are now shown below. However, the invention is not limited to these compounds.
    Figure US20050085642A1-20050421-C00003
    Figure US20050085642A1-20050421-C00004
    Figure US20050085642A1-20050421-C00005
    Figure US20050085642A1-20050421-C00006
    Figure US20050085642A1-20050421-C00007
    Figure US20050085642A1-20050421-C00008
  • The method for producing the compound represented by the general formula (I) is now described below. The bipyridine derivative of the invention can be produced synthetically by known methods, for example methods described in JP-A-2000-355580, JP-A-2001-261646, JP-A-2001-261647, JP-A-2001-261653 and the like. As one example, 4-acetylpyridines and 3-amino-2-propenals react together; then, the resulting reaction product reacts with ammonia or an ammonium salt to produce the compound. One example of the reaction schemes is shown. However, the invention is never limited to the example.
    Figure US20050085642A1-20050421-C00009
  • In the scheme, R1 has the same meanings as described above. R2 and R3 independently represent an appropriate substituent.
  • 3-Amino-2-propenals represented by the general formula (III) or (IV) (abbreviated as 3-amino-2-propenals hereinafter) for use in accordance with the invention can readily be available as commercial products or can readily be synthetically prepared in a simple manner by a method described in for example J. AM. Chem. Soc., 103, 3030 (1981); J. Chem. Soc. PERKINTRANS. I, 333 (1988); Collect. Czech. Chem. Commun., 61,1637 (1996); and Collect. Czech. Chem. Commun., 49, 2602 (1984).
  • Further, 4-acetylpyridines represented by the general formula (II) as a raw material (abbreviated as 4-aceylpyridines hereinbelow) can readily be available as commercial products. Acyl group can be introduced in pyridine compounds by Friedel-Crafts reaction (J. Org. Chem., 38, 1445 (1973); J. Am. Chem. Soc., 79, 1445 (1957); J. Am. Chem. Soc., 84, 813 (1962)).
  • In accordance with the invention, a base is preferably allowed to exist during the condensation reaction between 4-acetylpyridines and 3-amino-2-propenals. As the base for use in accordance with the invention, any base may be usable. Generally, metal alkoxides such as potassium t-butoxide, sodium t-butoxide, and sodium ethoxide; inorganic bases such as sodium hydride, metal sodium, sodium hydroxide and potassium hydroxide; organic bases such as triethylamine, 1,8-diazabicyclo[5.4.0]undec-7-ene and diisopropylamine are used.
  • Preferably, the base is potassium t-butoxide, sodium methoxide and sodium hydride. More preferably, the base is potassium t-butoxide. Additionally, two or more bases may be mixed and used. In case of using bases in mixture, the mix ratio may be appropriately determined. The amount of the base to be used is within a range of 0.5- to 5-fold moles, preferably 0.5- to 1.5-fold moles, more preferably 0.8- to 1.2-fold moles to the amount of 3-amino-2-propenals.
  • The reaction is conducted at a temperature of −78 to 200° C., preferably within a range of −30 to 100° C., more preferably within a range of −10 to 40° C. Generally, these reactions are on completion within 24 hours. In many cases, the elimination of the raw materials can be verified in 10 minutes to 12 hours.
  • After 4-acetylpyridines react with 3-amino-2-propenals as described above, a cyclization reaction is carried out. In case that R3 and R4 are both hydrogen atom in the general formula (III), the reaction proceeds with no addition of ammonia or an ammonium salt. In case that at least one of R3 and R4 is not hydrogen atom, however, ammonia or an ammonium salt is added as a nitrogen atom source for the pyridine ring. Any type of ammonia or an ammonium salt may be used as such. Generally, ammonia gas, ammonium chloride, ammonium acetate and ammonium formate are used. Ammonium chloride, ammonium acetate and ammonium formate are preferable, and ammonium acetate is more preferable. As to the amounts of them for use, the reaction is carried out satisfactorily within a range of 1- to 30-fold moles, preferably 1- to 15-fold moles, more preferably 3- to 6-fold moles per one mole of 4-acetylpyridines. Additionally, two or more ammonia types in different forms can be mixed together for use. The mix ratio for use in mixture may appropriately be determined.
  • The temperature of the cyclization reaction is within a range of −20 to 200° C., preferably within a range of 50 to 120° C., more preferably within a range of 70 to 100° C. Generally, these reactions are on completion within 24 hours. In many cases, the elimination of the raw materials can be confirmed in 10 minutes to 12 hours.
  • In accordance with the method of the invention, not any particular catalyst is needed. For the reaction of the reaction product resulting from the reaction of 4-acetylpyridines and 3-amino-2-propenals with ammonia or an ammonium salt, however, the reaction is completed in a shorter period of time, advantageously, when an acid catalyst is used. As the acid catalyst, any acid catalysts may be used. As such acid catalyst, inorganic acids such as sulfuric acid and hydrochloric acid, organic acids such as p-toluenesulfonic acid, formic acid, acetic acid, and propionic acid, and ion exchange resins of strong acidity, such as Amberlite and Amberlist can be used. Preferable are formic acid, acetic acid and propionic acid capable of retaining the inside of the reaction system at weak acidity. More preferable is acetic acid.
  • In accordance with the invention, satisfactorily, the use of a reaction solvent is not essential throughout all the steps. If necessary, however, any polar solvents or non-polar solvents may be used, including for example water; aromatic solvents such asbenzene, toluene, xylene, chlorobenzene, and dichlorobenzene; polar solvents such as pyridine, acetonitrile, N,N-dimethylformamide, N,N-dimethylacetamide, N-methylpyrrolidone, and dimethylsulfoxide; ester solvents such as methyl acetate, ethyl acetate and butyl acetate; alcoholic solvents such as methanol, ethanol, isopropyl alcohol, butanol, and t-butanol; ether solvents such as diethyl ether, diisopropyl ether, dibutyl ether, methyl t-butyl ether, and tetrahydrofuran. Preferable are alcoholic solvents, polar solvents, and ether solvents. More preferable are methanol, dimethylsulfoxide and tetrahydrofuran. Additionally, two or solvents can be used in mixture. In case of using solvents in mixture, the mix ratio may appropriately be determined. As to the amount of the reaction solvent, the reaction solvent is used within a range of 0.1- to 50-fold by weight, preferably 0.5- to 30-fold by weight, more preferably 1- to 10-fold by weight to 4-acetylpyridines.
  • The method for purifying the bipyridine derivative as the object substance after completion of the reaction includes extraction using water and an organic solvent such as ethyl acetate or toluene which can be partitioned from water, recrystallization using alcohol, hexane, toluene and the like, column purification using silica gel or alumina or the like as an immobilization bed, distillation and the like. These methods may be used singly or in combination of two or more thereof, for purification, to obtain the object substance at high purity.
  • The invention is now described specifically in the following Examples. However, the invention is not limited to them. Herein, the structural analysis was done by 1H-NMR and on mass spectrum.
    • EXAMPLE 1 Synthesis of 5-nitro-2,4′-bipyridine [(I)-1]
  • 3-(Dimethylamino)-2-nitro-2-propenal (60.5 g) was dissolved in tetrahydrofuran (500 ml). To the resulting solution were added 4-acetylpyridine (48.5 g) and potassium t-butoxide (121.14 g), for agitation at 30° C. for 30 minutes. After ammonium acetate (185 g) and acetic acid (140 ml) were added, reaction was progressed at an inner temperature of 95° C. for 4 hours while tetrahydrofuran was distilled off. To the reaction solution was added aqueous 25% NaOH solution (400 ml), for crystallization. The resulting crystal was dried to obtain the object compound in pale dark brown crystal (58 g; yield of 72%).
    • EXAMPLE 2 Synthesis of 5-cyano-2,4′-bipyridine [(I)-2]
  • By the same method as in Example 1,5-bromo-2,4′-bipyridine was prepared. The resulting 5-bromo-2,4′-bipyridine (7.0 g) was dissolved in N,N-dimethylacetamide (15 ml), followed by addition of copper (I) cyanide (2.8 g), for agitation at 140° C. for 3 hours. After the reaction solution was cooled, aqueous 25% NaOH solution (10 ml) was added to deposit a crystal, which was filtered and recovered, to obtain the object substance (4.5 g; yield of 83%).
    • EXAMPLE 3 Synthesis of 5-formyl-2,4′-bipyridine [(I)-3]
  • 5-Bromo-2,4′-bipyridine (7.0 g) obtained in the same manner as in Example 2 was dissolved in anhydrous tetrahydrofuran (50 ml), to which a 1.6 mol/L solution (20 ml) of n-BuLi in hexane was added at −70° C. or less, followed by addition of N,N-dimethylformamide (4.2 g), for agitation for 3 hours while the inner temperature was retained at −78° C. After the reaction solution was dropwise added to aqueous saturated sodium carbonate solution (200 ml), followed by extraction three times into toluene (300 ml), concentration and drying, the object substance (4.6 g; yield of 83%) was recovered.
    • EXAMPLE 4 5-Carboxamide-2,4′-bipyridine [(I)-4]
  • 5-Amino-2,4′-bipyridine (6.8 g) obtained in Example 3 was added to ethyl acetate (200 ml), to which acetic anhydride (4.3 g) was added. Triethylamine (8.1 g) was dropwise added. After reflux under heating for one hour, concentration and drying, the object substance (7.8 g; yield of 92%) was obtained.
    • EXAMPLE 5 Synthesis of 5-amino-2,4′-bipyridine [(I)-5]
  • 5-Nitro-2,4′-bipyridine (10 g) obtained in Example 1 was added to ethanol (400 ml). 10% Pd—C (50% wet with water) (0.14 g) was added, and then, hydrazine.monohydrate (10 g) was dropwise added, for reflux under heating for 3 hours. The reaction solution was filtered and concentrated. The resulting crystal was recrystallized in ethyl acetate, to obtain the object substance (8.13 g; yield of 95%).
    • EXAMPLE 6 Synthesis of 5-acetamide-2,4′-bipyridine [(I)-6]
  • 5-Amino-2,4′-bipyridine (6.8 g) obtained in Example 5 was added to ethyl acetate (50 ml), to which acetic anhydride (8.5 g) was added. Triethylamine (16.2 g) was dropwise added, for reflux under heating for one hour. The reaction solution was concentrated. The resulting deposited crystal was obtained by filtration, and then rinsed in 10 ml of ethyl acetate, to obtain the object substance (7.8 g; yield of 92%).
  • Table 1 shows the physico-chemical values of the object substances obtained in Examples 1 through 6.
    TABLE 1
    Examples Melting point (° C.) MS [M + H+]
    1 203-204 201
    2 218-220 181
    3 114-115 184
    4 220-229 199
    5 238-240 171
    6 208-209 213
  • Figure US20050085642A1-20050421-C00010
  • In the same manner, the following compounds were obtained.
    Figure US20050085642A1-20050421-C00011
  • The pyridine derivatives obtained in accordance with the invention are useful as intermediates for pharmaceutical products, agricultural chemicals, electrophotographic photosensitive materials, dyes and the like.

Claims (3)

1. A bipyridine derivative represented by the general formula (I) and a salt thereof:
Figure US20050085642A1-20050421-C00012
Wherein R1 represents an alkyl group with 2 to 20 carbon atoms having a substituent, substituted or unsubstituted aminomethyl group, trifluoromethyl group, substituted or unsubstituted thiomethyl group, substituted or unsubstituted alkenyl group, substituted or unsubstituted alkoxy group, substituted or unsubstituted aryloxy group, substituted carbonyl group, substituted sulfonyl group, unsubstituted or monosubstituted carbamoyl group, unsubstituted or monosubstituted sulfamoyl group, substituted or unsubstituted thiol group, unsubstituted or monosubstituted amino group, substituted carbonylamino group, substituted or unsubstituted ureido group, nitro group, cyano group, formyl group or an equivalent thereof, iodine atom or fluorine atom.
2. The bipyridine derivative and a salt thereof according to claim 1, wherein R1 represents an alkyl group with 2 to 20 carbon atoms having a substituent, an alkoxy group with 1 to 20 carbon atoms, which may have a substituent, an alkylthio group with 1 to 20 carbon atoms, which may have a substituent, unsubstituted or monosubstituted amino group, nitro group, formyl group, cyano group, unsubstituted or monosubstituted carbamoyl group or substituted carbonylamino group.
3. The bipyridine derivative and a salt thereof according to claim 1, wherein R1 represents unsubstituted amino group, nitro group, formyl group, cyano group, unsubstituted carbamoyl group or carbonylamino group substituted with a lower alkyl group.
US10/916,530 2003-07-07 2004-08-12 Bipyridine Derivatives Expired - Fee Related US7301029B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JPP.2003-271433 2003-07-07
JP2003271433A JP2005029517A (en) 2003-07-07 2003-07-07 New bipyridine derivative

Publications (2)

Publication Number Publication Date
US20050085642A1 true US20050085642A1 (en) 2005-04-21
US7301029B2 US7301029B2 (en) 2007-11-27

Family

ID=34209307

Family Applications (1)

Application Number Title Priority Date Filing Date
US10/916,530 Expired - Fee Related US7301029B2 (en) 2003-07-07 2004-08-12 Bipyridine Derivatives

Country Status (2)

Country Link
US (1) US7301029B2 (en)
JP (1) JP2005029517A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007026920A3 (en) * 2005-09-02 2007-06-28 Astellas Pharma Inc Amide derivatives as rock inhibitors
WO2024099430A1 (en) * 2022-11-10 2024-05-16 西藏海思科制药有限公司 Pharmaceutical composition comprising aak1 inhibitor

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834471A (en) * 1993-08-06 1998-11-10 Smithkline Beecham P.L.C. Amide derivatives as 5HT1D receptor antagonists
US6359134B1 (en) * 1997-05-30 2002-03-19 Takeda Chemical Industries, Ltd. Sulfonamide derivatives, their production and use
US6747023B1 (en) * 1998-08-11 2004-06-08 Daiichi Pharmaceutical Co., Ltd. Sulfonyl derivatives
US20050222410A1 (en) * 2002-04-27 2005-10-06 Stokes Elaine Sophie E Inhibitors of histone deacetylase

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4603646B2 (en) 1999-11-15 2010-12-22 富士フイルムファインケミカルズ株式会社 Novel dipyridyl derivatives

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834471A (en) * 1993-08-06 1998-11-10 Smithkline Beecham P.L.C. Amide derivatives as 5HT1D receptor antagonists
US6359134B1 (en) * 1997-05-30 2002-03-19 Takeda Chemical Industries, Ltd. Sulfonamide derivatives, their production and use
US6747023B1 (en) * 1998-08-11 2004-06-08 Daiichi Pharmaceutical Co., Ltd. Sulfonyl derivatives
US20050222410A1 (en) * 2002-04-27 2005-10-06 Stokes Elaine Sophie E Inhibitors of histone deacetylase

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007026920A3 (en) * 2005-09-02 2007-06-28 Astellas Pharma Inc Amide derivatives as rock inhibitors
US8211919B2 (en) 2005-09-02 2012-07-03 Astellas Pharma Inc. Amide derivatives as rock inhibitors
WO2024099430A1 (en) * 2022-11-10 2024-05-16 西藏海思科制药有限公司 Pharmaceutical composition comprising aak1 inhibitor

Also Published As

Publication number Publication date
US7301029B2 (en) 2007-11-27
JP2005029517A (en) 2005-02-03

Similar Documents

Publication Publication Date Title
US8129539B2 (en) Process for the preparation of 2-substituted-5-(1-alkylthio)alkylpyridines
US5011995A (en) Process for the preparation of optically active secondary amines
Kanakaraju et al. Ammonium acetate catalyzed an efficient one-pot three component synthesis of pyrano [3, 2-c] chromene derivatives
US20060287541A1 (en) Method for producing nitrile compound, carboxylic acid compound or carboxylate compound
ES2323288T3 (en) Phenylacetylene derivatives that have affinity for the MGLURS RECEIVER.
US6951935B2 (en) Heteroatom-substituted porphyrins and methods for synthesis of same
Vereshchagin et al. Four-component stereoselective synthesis of tetracyano-substituted piperidines
Noruzian et al. “On-water” one-pot four-component synthesis of novel 1 H-furo [2, 3-c] pyrazole-4-amine derivatives
JP2008530117A (en) Process for producing 2,3-disubstituted indoles
US7301029B2 (en) Bipyridine Derivatives
EP1559711B1 (en) Preparation of pyridine derivatives using pyrimidinium derivatives as intermediates
Joseph et al. An exclusive approach to 3, 4-disubstituted cyclopentenes and alkylidene cyclopentenes via the palladium catalyzed ring opening of azabicyclic olefins with aryl halides
JP2001261653A (en) Method for synthesizing pyridine derivative
Degani et al. A single-step, mild, neutral, catalyst-free method for cyanohydrin synthesis
US8563763B2 (en) Composition, synthesis and use of isonitriles
Nowicki et al. Highly Selective Preparation of a Chiral Quaternary Allyl Aryl Piperidinedione by Palladium‐Catalyzed Asymmetric Allylation Under Solid–Liquid Phase‐Transfer Catalysis
JP2001097950A (en) New pyridine derivative
CN106220554B (en) A kind of preparation method of arylpyridine and derivative thereof
JP2001261647A (en) Method for producing pyridine derivative
JPH0859591A (en) 2-(aryliminomethyl)-3-dialkylaminoacrylonitrile compound,itsproduction,and its use
US4810814A (en) Preparation of cyanoalkylphenols
Shukla et al. Copper‐Catalyzed Decarbonylative Synthesis of Pyridyl‐Substituted Ureas by the Reaction of 2‐Aminopyridines with N‐Arylmaleimides as N‐Arylcarbamoyl Surrogate
CA1100514A (en) Imidazolidine derivatives useful as insecticides and acaricides
US20090240067A1 (en) Method of producing a bisbenzodithiol compound
JP2005239672A (en) Method for producing pyridine derivative

Legal Events

Date Code Title Description
AS Assignment

Owner name: SANKIO CHEMICAL CO., LTD., JAPAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KUWABARA, HIROKAZU;SONODA, TAKAYUKI;SAITOH, HIROMITSU;AND OTHERS;REEL/FRAME:016077/0292

Effective date: 20041108

AS Assignment

Owner name: FUJIFILM FINECHEMICALS CO., LTD.,JAPAN

Free format text: CHANGE OF NAME;ASSIGNOR:SANKIO CHEMICAL CO., LTD.;REEL/FRAME:017613/0333

Effective date: 20060213

Owner name: FUJIFILM FINECHEMICALS CO., LTD., JAPAN

Free format text: CHANGE OF NAME;ASSIGNOR:SANKIO CHEMICAL CO., LTD.;REEL/FRAME:017613/0333

Effective date: 20060213

FEPP Fee payment procedure

Free format text: PAT HOLDER NO LONGER CLAIMS SMALL ENTITY STATUS, ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: STOL); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

REFU Refund

Free format text: REFUND - SURCHARGE, PETITION TO ACCEPT PYMT AFTER EXP, UNINTENTIONAL (ORIGINAL EVENT CODE: R2551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FPAY Fee payment

Year of fee payment: 4

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20151127